Business Context and Reporting Period
Company: Financial Institutions, Inc. (FISI)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2026
Business Overview: FISI is a financial holding company operating primarily through its subsidiary, Five Star Bank, providing diversified financial services in Western and Central New York, with additional commercial loan production in the Mid-Atlantic region. It also operates Courier Capital, LLC, an investment advisory and wealth management firm.
Key Financial Metrics
| Metric | Q2 2026 | Q2 2025 | 6 Months 2026 | 6 Months 2025 |
|---|---|---|---|---|
| Net Income | $21.2 million | $17.5 million | $42.2 million | $34.4 million |
| Diluted EPS | $1.04 | $0.85 | $2.08 | $1.66 |
| Net Interest Income | $53.4 million | $49.1 million | $105.4 million | $96.0 million |
| Net Interest Margin (Tax-Equivalent) | 3.70% | 3.49% | 3.53% | 3.42% |
| Noninterest Income | $11.0 million | $10.6 million | $21.6 million | $21.0 million |
| Noninterest Expense | $35.6 million | $35.7 million | $71.2 million | $69.4 million |
| Efficiency Ratio | 55.33% | 59.68% | 56.18% | 59.24% |
| Total Assets | $6.33 billion | $6.27 billion (Dec 31, 2025) | — | — |
| Total Loans (Net) | $4.71 billion | $4.61 billion (Dec 31, 2025) | — | — |
| Total Deposits | $5.30 billion | $5.21 billion (Dec 31, 2025) | — | — |
| Cash and Cash Equivalents | $99.2 million | $108.8 million (Dec 31, 2025) | — | — |
| Allowance for Credit Losses | $47.5 million | $47.3 million (Dec 31, 2025) | — | — |
Material Changes vs. Prior Period
- Profitability Growth: Net income increased 21% year-over-year for Q2 2026, driven by a $4.2 million increase in net interest income and a 3.2% increase in noninterest income.
- Net Interest Margin Expansion: NIM expanded to 3.70% in Q2 2026 from 3.49% in Q2 2025. This was primarily due to a 39-basis point decrease in the cost of interest-bearing liabilities, partially offset by a 12-basis point decrease in the yield on interest-earning assets.
- Asset Growth: Total loans increased by $95.1 million from year-end 2025, driven by organic growth in commercial mortgages. Average loans increased $139.2 million compared to Q2 2025.
- Expense Management: Noninterest expense remained relatively flat in Q2 2026 compared to Q2 2025, despite a 6% increase in salaries and employee benefits, resulting in an improved efficiency ratio.
- Asset Quality: Net charge-offs decreased significantly to $1.3 million (0.11% annualized) in Q2 2026 compared to $4.1 million (0.36% annualized) in Q2 2025. Non-performing loans increased to $39.0 million, primarily due to a well-collateralized commercial business loan moving to nonaccrual status.
Guidance, Outlook, and Risks
Management Commentary:
- Management attributes the increase in net interest income to loan growth and lower funding costs due to deposit repricing.
- Investment advisory income increased 14% year-over-year as assets under management at Courier Capital surpassed $4.0 billion.
- The company maintains a "well-capitalized" status under Basel III rules, with a Tier 1 Capital Ratio of 11.76% and Total Risk-Based Capital Ratio of 14.20% as of June 30, 2026.
- Share repurchases: No shares were repurchased in Q2 2026. 506,313 shares remain available under the current program.
Risks and Contingencies:
- Interest Rate Risk: The company is exposed to interest rate fluctuations. Rate shock simulations indicate net interest income would decrease by 1.74% to 5.66% in scenarios where rates fall by 100 to 300 basis points.
- Credit Risk: Concentration in commercial real estate (CRE) loans, which comprise 45% of total loans. Approximately 70% of office exposure relates to Class B or medical office space.
- Regulatory Risk: The company serves New York State-licensed cannabis businesses, carrying uncertainty regarding federal enforcement posture.
- Unrealized Losses: The available-for-sale securities portfolio held a net unrealized loss of $49.2 million as of June 30, 2026, driven by market interest rate increases. Management does not believe these are credit-related impairments.
Investor Verification Checklist
- Deposit Cost Stability: Verify the sustainability of the 39-basis point reduction in the cost of interest-bearing liabilities in a competitive market.
- CRE Concentration: Review the specific performance of the Class B and medical office space exposure within the commercial real estate portfolio.
- Non-Performing Assets: Monitor the resolution of the specific commercial business loan that moved to nonaccrual status in Q1 2026, which drove the increase in non-performing loans.
- Securities Portfolio: Assess the impact of the $49.2 million unrealized loss on available-for-sale securities on regulatory capital and potential future liquidity needs if sales become necessary.
- Share Repurchase Program: Confirm the status of the remaining 506,313 shares available for repurchase and management's intent to utilize the program given the current capital position.